Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.
about
An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domainVaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalkAntibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.Current approaches to vaccine preparation.Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor.Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challengeLocalization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.The inducible blood--brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein.Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.Basic fibroblast growth factor in atria and ventricles of the vertebrate heart.Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
P2860
Q27486019-FA41F24D-5294-4EDE-B3A7-25EA2FF93F9FQ27486872-A43B6C94-14AB-4CC6-9535-F6A738BDAFFCQ30376254-4F14664A-35CA-4386-AC45-BDC77ABD3DA4Q30879279-BDC19618-2EF8-4ED1-929E-FD056569E523Q34688016-835FD0AA-2E89-4546-8C4D-3D4AE566BA95Q35599351-99FD825B-33B4-4099-B73F-A1E7B1947E57Q36855019-20472C08-C815-4123-8A88-3FC73B5E3030Q36906684-9018689B-B4F9-4649-A3E8-9E8B40BC01F0Q37688703-F2315C45-7063-47F6-847D-8B8824F30998Q37695463-D05EA994-6EBF-4348-8BD4-6DAE3117AB38Q40044748-18BEA6E1-1F18-48E9-BCFD-A692CF823219Q41217605-288F0E75-2B8C-4A2D-BCD4-6FFE7C676104Q41431019-17A25B81-7FEF-4188-9071-495CC9E1B7E7Q41588301-5F9139EF-6787-49DF-BCB6-97EB74DCB5E7Q41831486-EEB3A059-8BF4-4376-8AA5-3B7A08EDBCD5Q50125851-B46BAA63-FCB8-4EAD-8FE3-ECCCD2518976
P2860
Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Immunity and protection agains ...... igenic sites of hemagglutinin.
@ast
Immunity and protection agains ...... igenic sites of hemagglutinin.
@en
type
label
Immunity and protection agains ...... igenic sites of hemagglutinin.
@ast
Immunity and protection agains ...... igenic sites of hemagglutinin.
@en
prefLabel
Immunity and protection agains ...... igenic sites of hemagglutinin.
@ast
Immunity and protection agains ...... igenic sites of hemagglutinin.
@en
P2093
P2860
P356
P1476
Immunity and protection agains ...... igenic sites of hemagglutinin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.8.2461
P407
P577
1984-04-01T00:00:00Z